• Info
  • Significant Ownership

Significant Ownership of Everest Medicines Ltd

Signature - Title
/s/ Ian Ying WOO - Ian Ying WOO, CFO&President
Location
Shanghai
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Everest Medicines Ltd.

Notify me when Everest Medicines Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Everest Medicines Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IMAB I-MAB Ordinary shares, par value US$0.0001 per share 16% $36,146,009 42,524,716 Everest Medicines Limited 05 Aug 2025

Schedules 13D/G Reported by Everest Medicines Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.